# A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended

> **NCT00922090** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1494 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00922090
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1494 (ACTUAL)
- **Last updated:** 2010-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922090, "A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00922090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*